Investigating variations in the AMH signaling pathway related to PCOS
Official title: AMH signaling pathway variation in PCOS
Funded at Northwestern University at Chicago · NIH-10818355 · Data updated 2026-11-12
This study is looking at how certain genes related to a hormone called anti-Müllerian hormone might affect women with Polycystic Ovary Syndrome (PCOS), with the goal of helping to improve understanding and treatment of this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | June 1, 2020 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $598,854 |
| NIH project number | 5R01HD100630-05 |
| Project ID | NIH-10818355 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women diagnosed with Polycystic Ovary Syndrome (PCOS), particularly those experiencing infertility or related metabolic issues.
✕Less likely to help
Patients without a diagnosis of PCOS or those with unrelated reproductive or metabolic disorders may not benefit from this research.
What this research studies
This research focuses on Polycystic Ovary Syndrome (PCOS), a common condition affecting reproductive-age women that can lead to infertility and other health issues. The study aims to identify genetic variations in the anti-Müllerian hormone (AMH) gene and its receptor, which may contribute to the development and severity of PCOS. By conducting whole genome sequencing, researchers will analyze the impact of these genetic variants on hormone signaling and their potential role as biomarkers for PCOS. This could lead to better understanding and management of the condition for affected individuals.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for women with PCOS.
How similar studies have gone: Previous research has shown promise in identifying genetic factors related to PCOS, but this study aims to explore novel genetic variants that have not been extensively tested.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Urbanek, Margrit — Northwestern University at Chicago
- Study coordinator: Urbanek, Margrit
Related research
Other NIH-funded projects on the same topics.
-
Genetically Validated PCOS Subtypes for Better Diagnosis and Risk Stratification
Aimed at women with polycystic ovary syndrome (PCOS), this project uses genetic data and patient characteristics to define distinct PCOS subtypes and improve how we diagnose and estimate risk.
-
Understanding how PCOS develops during adolescence
This grant looks at how polycystic ovary syndrome begins in teenagers and what early signs help doctors diagnose it accurately.
-
Genetically guided PCOS subtypes to improve diagnosis and risk stratification
Aims to use genetic patterns to identify PCOS subtypes so doctors can diagnose it more precisely and tailor risk predictions for each patient.
-
Using inositol to improve reproductive and metabolic health in women with PCOS
This study is looking at how taking inositol might help women with polycystic ovary syndrome (PCOS) by checking its effects on hormone levels and overall health over three months.
-
Understanding how dopamine affects reproductive hormone release in women with PCOS
This study is looking at how certain brain cells that control hormone release can help women with reproductive issues like PCOS and hypothalamic amenorrhea, and it’s testing if a compound that affects these cells can help balance hormone levels.
-
Investigating how genetic variations in gonadotropin pathways affect PCOS
This study is looking at how our genes might play a role in Polycystic Ovary Syndrome (PCOS) to help find better treatments for women dealing with this condition.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.